Narayana Hrudayalaya quarterly results

Q1 FY27 · Apr–Jun 2026
₹ croreQ1 FY27Q1 FY26Change
Revenue2,6841,507+78.0%
EBITDA470337+39.4%
EBITDA margin17.5%22.4%−4.9 pts
Profit before tax262231+13.4%
Net profit207197+5.4%
EPS₹10.20₹9.68+5.4%

Every quarter

₹ crore except per share
Tap a line for its trendQ1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025Q4 FY25Mar 2025Q3 FY25Dec 2024Q2 FY25Sep 2024Q1 FY25Jun 2024Q4 FY24Mar 2024Q3 FY24Dec 2023Q2 FY24Sep 2023Earlier quartersAlpha Plus
2,6842,5942,1511,6441,5071,4751,3671,4001,3411,2791,2041,305
Earlier quartersEvery year the company has filed comes with Alpha Plus.
35.529.223.224.023.826.818.423.623.523.917.918.4
2,7192,6232,1741,6681,5311,5021,3851,4241,3641,3031,2221,324
Expenses
520525407323305305270317282294259284
−6.0−18.0−26.0−0.70.4−0.16.6−16.46.3−20.4−14.90.5
725749459299296275277282276249254255
86.891.365.042.345.240.736.635.134.028.025.122.9
15615412287.584.382.570.065.161.764.863.255.3
975828943620569537506509473462426457
2,4572,3291,9711,3711,3001,2411,1661,1921,1331,0781,0131,075
470510367403337358307308304295279308
314356245315253275237243242230216253
Profit
262294203297231261219232232226209248
0.0−0.0−50.90.00.0−8.40.00.00.00.00.00.0
262294152297231253219232232226209248
55.776.130.136.234.242.028.829.129.951.226.129.5
−2.6−12.0−7.81.00.614.8−3.13.90.3−16.4−5.7−7.8
53.164.122.337.234.856.825.833.030.234.820.521.7
−1.9−2.0−1.9−1.3−0.40.00.00.00.00.00.00.0
207224127258197197193199201191188227
207228128258196196193199201191188227
0.0−4.0−1.30.20.71.00.00.00.00.00.00.0
−13.296.530.369.40.5−5.936.45.3−2.14.4−1.114.6
194320157328197191229204199195187241
207224127258197197193199201191188227
0.10.10.10.10.10.10.10.20.10.10.10.1
Per share
₹10.20₹11.02₹6.24₹12.72₹9.68₹9.71₹9.50₹9.78₹9.92₹9.39₹9.26₹11.16
₹10.20₹11.02₹6.24₹12.72₹9.68₹9.71₹9.50₹9.78₹9.92₹9.39₹9.26₹11.16
Continuing & discontinued operations
0.0−3.3−1.30.20.71.80.00.00.00.00.00.0
0.00.70.00.00.10.70.00.00.00.00.00.0
Other comprehensive income — detail
−13.296.530.369.40.5−5.9——————
−6.50.8−1.3−1.90.9−0.0−0.5−0.7−4.1−0.5−0.80.1
−1.20.6−0.20.1−0.2−0.4——————
——————−0.1−0.2−0.9−0.2−0.20.0
−7.996.431.371.4−0.6−6.336.85.81.14.7−0.514.6
0.00.0−0.10.00.00.0——————
——————0.0−0.0−0.0−0.00.00.1
194320157328197191229204199195187241
0.10.10.10.10.10.10.10.20.10.10.10.1
Per share — as-filed variants
₹10.20₹11.22₹6.30₹12.71₹9.65₹9.66₹9.50₹9.78₹9.92₹9.39₹9.26₹11.16
₹10.20₹11.22₹6.30₹12.71₹9.65₹9.66₹9.50₹9.78₹9.92₹9.39₹9.26₹11.16
₹0.00−₹0.20−₹0.06₹0.01₹0.03₹0.05₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
₹0.00−₹0.20−₹0.06₹0.01₹0.03₹0.05₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
2,1692,0871,7701,3221,2011,1701,0901,1001,0531,0069591,021
80.8%80.5%82.3%80.4%79.7%79.3%79.8%78.6%78.5%78.6%79.7%78.2%
Adjusted (ex-exceptional items) — derived
262294203297231261219232232226209248
0.0−0.0−50.90.00.0−8.40.00.00.00.00.00.0
207224170258197204193199201191188227
₹10.20₹11.02₹8.38₹12.72₹9.68₹10.03₹9.50₹9.78₹9.92₹9.39₹9.26₹11.16
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NH₹1,714.50

Narayana Hrudayalaya Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPMAXHEALTHFORTISNEULANDLABNATCOPHARMLALPATHLABSAILIFECOHANCEMcap ₹35,038 Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations1,305.21,203.61,279.41,341.01,400.01,366.71,475.41,507.31,643.82,151.22,593.82,683.6
Other Income18.417.923.923.523.618.426.823.824.023.229.235.5
Total Income1,323.61,221.51,303.31,364.41,423.61,385.01,502.31,531.11,667.82,174.42,623.02,719.1
Expenses
+ Purchases of Stock-in-Trade284.0259.2293.9281.9316.6269.7305.4305.4323.0407.4524.6520.3
+ Changes in Inventories0.5-14.9-20.46.3-16.46.6-0.10.4-0.7-26.0-18.0-6.0
+ Employee Benefit Expense255.3254.2249.4276.4282.1277.3275.4295.5299.1459.5748.9724.8
+ Finance Costs22.925.128.034.035.136.640.745.242.365.091.386.8
+ Depreciation & Amortisation55.363.264.861.765.170.082.584.387.5122.3153.8156.1
+ Other Expenses457.4426.2462.0472.5509.3506.1537.0569.0620.0943.0828.3974.8
Total Expenses1,075.31,012.91,077.71,132.81,191.81,166.21,240.91,299.81,371.01,971.22,328.92,456.8
EBITDA308.1278.9294.6303.9308.4307.0357.7337.0402.5367.2510.0469.7
EBIT252.8215.8229.8242.2243.3237.0275.2252.6315.0245.0356.2313.6
Profit
PBT before Exceptional Items248.4208.6225.6231.7231.8218.8261.4231.3296.8203.2294.2262.3
+ Exceptional Items0.00.00.00.00.00.0-8.40.00.0-50.9-0.00.0
Pretax Income248.4208.6225.6231.7231.8218.8253.0231.3296.8152.2294.1262.3
+ Current Tax29.526.151.229.929.128.842.034.236.230.176.155.7
+ Deferred Tax-7.8-5.7-16.40.33.9-3.114.80.61.0-7.8-12.0-2.6
Tax Expense21.720.534.830.233.025.856.834.837.222.364.153.1
+ Net Movement in Regulatory Deferral Balances0.00.00.00.00.00.00.0-0.4-1.3-1.9-2.0-1.9
Net Income226.7188.1190.8201.5198.8193.1197.3196.7258.5126.8224.0207.3
+ Net Income — Continuing Ops226.7188.1190.8201.5198.8193.1196.2196.1258.3128.1228.0207.3
+ Net Income — Discontinued Ops0.00.00.00.00.00.01.00.70.2-1.3-4.00.0
+ Other Comprehensive Income14.6-1.14.4-2.15.336.4-5.90.569.430.396.5-13.2
Total Comprehensive Income241.3187.0195.2199.4204.1229.4191.4197.2327.9157.1320.5194.0
Net Income to Common226.6188.0190.7201.4198.6192.9197.2196.7258.4126.7223.9207.2
Minority Interest0.10.10.10.10.20.10.10.10.10.10.10.1
Per Share
Basic EPS11.169.269.399.929.789.509.719.6812.726.2411.0210.20
Diluted EPS11.169.269.399.929.789.509.719.6812.726.2411.0210.20
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.00.00.00.00.01.80.70.2-1.3-3.30.0
+ Tax — Discontinued Operations0.00.00.00.00.00.00.70.10.00.00.70.0
Other Comprehensive Income — detail
+ Other Comprehensive Income——————-5.90.569.430.396.5-13.2
+ Items NOT to be Reclassified to P&L0.1-0.8-0.5-4.1-0.7-0.5-0.00.9-1.9-1.30.8-6.5
+ Tax on Items NOT to be Reclassified——————-0.4-0.20.1-0.20.6-1.2
+ Tax on Items NOT to be Reclassified — alt tag0.0-0.2-0.2-0.9-0.2-0.1——————
+ Items to be Reclassified to P&L14.6-0.54.71.15.836.8-6.3-0.671.431.396.4-7.9
+ Tax on Items to be Reclassified——————0.00.00.0-0.10.00.0
+ Tax on Items to be Reclassified — alt tag0.10.0-0.0-0.0-0.00.0——————
Comprehensive Income — Owners of Parent241.2186.9195.1199.3204.0229.3191.4197.1327.8157.0320.5194.0
Comprehensive Income — Non-controlling Interests0.10.10.10.10.20.10.10.10.10.10.10.1
Per Share — as-filed variants
Basic EPS — Continuing Operations11.169.269.399.929.789.509.669.6512.716.3011.2210.20
Diluted EPS — Continuing Operations11.169.269.399.929.789.509.669.6512.716.3011.2210.20
Basic EPS — Discontinued Operations0.000.000.000.000.000.000.050.030.01-0.06-0.200.00
Diluted EPS — Discontinued Operations0.000.000.000.000.000.000.050.030.01-0.06-0.200.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,020.8959.41,005.91,052.71,099.81,090.31,170.11,201.51,321.61,769.72,087.22,169.4
Gross Margin %78.2079.7178.6278.5178.5679.7879.3179.7180.4082.2780.4780.84
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)248.4208.6225.6231.7231.8218.8261.4231.3296.8203.2294.2262.3
− Exceptional Items (reconciliation)0.00.00.00.00.00.0-8.40.00.0-50.9-0.00.0
Net Income Adj (tax-effected)226.7188.1190.8201.5198.8193.1203.8196.7258.5170.3224.0207.3
EPS Adj11.169.269.399.929.789.5010.039.6812.728.3811.0210.20
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Filed Debt Equity——1.001.001.001.000.670.580.581.301.291.24
Filed Dscr——3.003.003.003.002.572.413.161.932.062.23
Filed Iscr——9.008.008.007.007.226.117.993.314.204.00
Paid Up Equity Capital204.4204.4204.4204.4204.4204.4204.4204.4204.4204.4204.4204.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Narayana Hrudayalaya Q2 FY27 results date

Narayana Hrudayalaya (NSE: NH) will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, according to the board-meeting notice it filed on 26 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹207 crore, up 5.4% from ₹197 crore in Q1 FY26 and down 7.5% from ₹224 crore in Q4 FY26. Revenue from operations was ₹2,684 crore, up 78.0% year on year and up 3.5% from the previous quarter.

Board-meeting notice filed
26 October 2026
Q2 FY26 results (a year earlier)
14 November 2025
Q1 FY27 results (the latest)
31 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date
30 October 2026Friday · notice filed 26 Oct
Q1 FY27 net profit
₹207 Cr+5.4% vs Q1 FY26−7.5% vs Q4 FY26
Q1 FY27 revenue
₹2,684 Cr+78.0% vs Q1 FY26+3.5% vs Q4 FY26
Q1 FY27 operating margin
11.7%−5.1 pts vs Q1 FY26−2.0 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier)
₹258 CrRevenue ₹1,644 Cr
Q1 FY27 EPS (basic)
₹10.20

Questions

When will Narayana Hrudayalaya announce its Q2 FY27 results?

On 30 October 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 26 October 2026). Last year it reported Q2 FY26 on 14 November 2025.

What were Narayana Hrudayalaya's Q1 FY27 results?

Consolidated net profit was ₹207 crore, up 5.4% from ₹197 crore in Q1 FY26 and down 7.5% from ₹224 crore in Q4 FY26. Revenue from operations was ₹2,684 crore, up 78.0% year on year and up 3.5% from the previous quarter.

What was Narayana Hrudayalaya's net profit in FY26?

Consolidated net profit was ₹806 crore in FY26 (April 2025–March 2026), up 2.0% from ₹790 crore in FY25. It was ₹789 crore in FY24 and ₹606 crore in FY23: up 32.9% over three years, 9.9% a year on average.

What will Narayana Hrudayalaya's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹258 crore and revenue from operations ₹1,644 crore. The latest quarter, Q1 FY27, had a net profit of ₹207 crore and revenue of ₹2,684 crore.

How has Narayana Hrudayalaya's profit changed over the last four quarters?

Net profit by quarter: ₹258 crore in Q2 FY26, ₹127 crore in Q3 FY26, ₹224 crore in Q4 FY26 and ₹207 crore in Q1 FY27. That is ₹816 crore over the four quarters, up 3.9% from ₹785 crore in the four quarters before. Revenue from operations: ₹1,644 crore, ₹2,151 crore, ₹2,594 crore and ₹2,684 crore.

What was Narayana Hrudayalaya's revenue in FY26?

Revenue from operations was ₹7,896 crore in FY26 (April 2025–March 2026), up 44.0% from ₹5,483 crore in FY25. It was ₹5,018 crore in FY24 and ₹4,525 crore in FY23: up 74.5% over three years, 20.4% a year on average.

Where do these Narayana Hrudayalaya figures come from?

From Narayana Hrudayalaya's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.